metformina sandoz
sandoz s.p.a. - metformina - metformina
metformina eg stada italia
eg s.p.a. - metformina - metformina
metformina alter
laboratori alter s.r.l. - metformina - metformina
tutecvi combi
viatris limited - metformina e vildagliptin - metformina e vildagliptin
metsunix
adamed s.r.l. - metformina e sitagliptina - metformina e sitagliptina
diesmit
bruno farmaceutici s.p.a. - metformina e sitagliptina - metformina e sitagliptina
yaltormin
pinewood laboratories limited - metformina - metformina
metformina rat.it. 60cpr 1000m
ratiopharm italia srl - metformina cloridrato - compresse rivestite - " 1000 mg compresse rivestite con film " 60 compresse
metformina rat.it. 40cpr 850mg
ratiopharm italia srl - metformina cloridrato - compresse rivestite - " 850 mg compresse rivestite con film " 40 compresse
sitagliptin / metformin hydrochloride sun
sun pharmaceutical industries europe b.v. - sitagliptin fumarate, metformin hydrochloride - diabete mellito, tipo 2 - farmaci usati nel diabete - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride sun is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride sun is indicated in combination with a sulphonylurea (i. , triplice terapia di associazione) in aggiunta alla dieta e all'esercizio fisico in pazienti non adeguatamente controllati il loro dosaggio massimo tollerato di metformina ed una sulfonilurea. sitagliptin/metformin hydrochloride sun is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. sitagliptin/metformin hydrochloride sun is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.